Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
McKesson
Colorcon
Merck

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR IMIQUIMOD


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Imiquimod

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00031759 ↗ Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia Completed National Cancer Institute (NCI) Phase 2 1999-06-01 RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
NCT00031759 ↗ Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia Completed Alliance for Clinical Trials in Oncology Phase 2 1999-06-01 RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
NCT00066872 ↗ Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer Completed Queen's Medical Centre Phase 3 2002-10-01 RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known if topical imiquimod is more effective than surgery in treating basal cell skin cancer. PURPOSE: This randomized phase III trial is studying how well topical imiquimod works compared to surgery in treating patients with basal cell skin cancer.
NCT00079300 ↗ Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer Completed National Naval Medical Center Phase 1 2004-01-01 RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating patients with basal cell skin cancer.
NCT00110682 ↗ Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses Completed 3M Phase 4 2005-04-01 Study Aims: - To compare the long-term efficacy and safety of imiquimod versus vehicle used as an adjunct to cryotherapy. - To assess and compare the recurrence rate and time to recurrence of the 2 different treatment groups. Hypothesis: The imiquimod arm will produce a more prolonged clearing of Actinic Keratoses (AK) compared to the vehicle arm.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Imiquimod

Condition Name

Condition Name for Imiquimod
Intervention Trials
Actinic Keratosis 20
Actinic Keratoses 10
Cervical Intraepithelial Neoplasia 7
Basal Cell Carcinoma 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Imiquimod
Intervention Trials
Keratosis, Actinic 35
Keratosis 35
Carcinoma 19
Carcinoma in Situ 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Imiquimod

Trials by Country

Trials by Country for Imiquimod
Location Trials
United States 313
United Kingdom 20
Germany 12
Austria 12
Canada 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Imiquimod
Location Trials
Florida 21
New York 21
California 19
Texas 17
Illinois 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Imiquimod

Clinical Trial Phase

Clinical Trial Phase for Imiquimod
Clinical Trial Phase Trials
Phase 4 23
Phase 3 35
Phase 2/Phase 3 6
[disabled in preview] 37
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Imiquimod
Clinical Trial Phase Trials
Completed 88
Recruiting 20
Terminated 17
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Imiquimod

Sponsor Name

Sponsor Name for Imiquimod
Sponsor Trials
National Cancer Institute (NCI) 18
Graceway Pharmaceuticals, LLC 16
MEDA Pharma GmbH & Co. KG 11
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Imiquimod
Sponsor Trials
Other 180
Industry 77
NIH 20
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Express Scripts
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.